CIK 0000868278 · Non-accelerated filer<br>Smaller reporting company
ProPhase Labs, Inc.
Sign in to watch- Ticker
- PRPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232577138
- Phone
- (215) 345-0919
- Business address
- 711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530
- Former names
- QUIGLEY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-03 | Karkus Ted William CEO & CHAIRMAN | Grant or award · Option (right to buy) | +500,000 | 500,000 | ||
| 2023-02-01 | Karkus Ted William CEO & CHAIRMAN | Option exercise | +500,000 | $0.60 | $300K | 3,852,087 |
| 2023-02-01 | Karkus Ted William CEO & CHAIRMAN | Shares withheld for taxes | −268,337 | $8.18 | $2.2M | 3,583,750 |
| 2023-02-01 | Karkus Ted William CEO & CHAIRMAN | Option exercise · Option (right to buy) | −500,000 | 0 | ||
| 2023-01-13 | Karkus Ted William CEO & CHAIRMAN | Option exercise | +600,000 | $0.60 | $360K | 3,671,318 |
| 2023-01-13 | Karkus Ted William CEO & CHAIRMAN | Shares withheld for taxes | −319,231 | $9.36 | $3.0M | 3,352,087 |
| 2023-01-13 | Karkus Ted William CEO & CHAIRMAN | Option exercise · Option (right to buy) | −600,000 | 500,000 | ||
| 2022-10-16 | Karkus Ted William CEO & CHAIRMAN | Option exercise | +600,000 | $0.60 | $360K | 3,388,609 |
| 2022-10-16 | Karkus Ted William CEO & CHAIRMAN | Shares withheld for taxes | −317,291 | $10.41 | $3.3M | 3,071,318 |
| 2022-10-16 | Karkus Ted William CEO & CHAIRMAN | Option exercise · Option (right to buy) | −600,000 | 1,100,000 | ||
| 2022-08-10 | Karkus Ted William CEO & CHAIRMAN | Option exercise | +600,000 | $0.60 | $360K | 3,105,214 |
| 2022-08-10 | Karkus Ted William CEO & CHAIRMAN | Shares withheld for taxes | −316,605 | $10.84 | $3.4M | 2,788,609 |
| 2022-08-10 | Karkus Ted William CEO & CHAIRMAN | Option exercise · Option (right to buy) | −600,000 | 1,700,000 | ||
| 2022-07-01 | Barr Jason Michael Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2022-07-01 | GLECKEL LOUIS MD Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2022-07-01 | Hirsch Warren Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2022-05-23 | Karkus Ted William CEO & CHAIRMAN | Option exercise | +450,000 | $2.00 | $900K | 2,783,471 |
| 2022-05-23 | Karkus Ted William CEO & CHAIRMAN | Shares withheld for taxes | −278,257 | $8.47 | $2.4M | 2,505,214 |
| 2022-05-23 | Karkus Ted William CEO & CHAIRMAN | Option exercise · Option (right to buy) | −450,000 | 0 | ||
| 2022-05-23 | Brady Monica L. Chief Accounting Officer | Option exercise | +25,000 | $2.15 | $54K | 32,428 |
Page 2 of 8 · 148 trades